Table 1.
Quality assessment | APS studies |
SLE studies | NPSLE studies |
|||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Arvanitakis et al. (2019) [20] | Homayoon et al. (2014) [21] | Zamproni et al. (2013) [22] | Erkan et al. (2010) [23] | Chapman et al. (2002) [24] | Whitelaw et al. (1999) [25] | Sarbu et al. (2015) [26] | Steup-Beekman et al. (2013) [27] | Abda et al. (2013) [28] | Zirkzee et al. (2012) [29] | Cantú-Brito et al. (2010) [30] | ||
Selection | ||||||||||||
1. Is the case definition adequate | ● | ● | ● | ● | ○ | ○ | ● | ● | ● | ● | ● | |
2. Representativeness of cases | ● | ● | ● | ○ | ○ | ○ | ● | ○ | ● | ○ | ○ | |
3. Ascertainment of exposure | ● | ● | ● | ● | ● | ● | ● | ● | ● | ● | ● | |
4. Outcome of interest was not present at start of study | ● | ● | ○ | ● | ● | ● | ● | ● | ○ | ○ | ● | |
Comparability | ||||||||||||
5. Study controls for most important factor | ● | ● | ○ | ● | ○ | ○ | ● | ○ | ○ | ○ | ○ | |
6. Study controls for second important factor | ● | ● | ○ | ● | ○ | ○ | ● | ○ | ○ | ○ | ○ | |
Outcome | ||||||||||||
7. Assessment of outcome | ● | ●● | ●● | ●● | ●● | ●● | ●● | ●● | ●● | ●● | ● | |
8. Statistical test (CS only) | ● | ● | ○ | ○ | ● | ● | ○ | ● | ● | ● | ||
9. Adequate follow up period for outcome of interest (LS only) | ● | |||||||||||
10. Adequacy of follow up of cohorts (LS only) | ● | ● | ||||||||||
Total score | 9/9 | 9/9 | 6/9 | 7/9 | 4/9 | 5/9 | 9/9 | 5/9 | 6/9 | 5/9 | 6/9 |
CS: cross-sectional studies; LS: longitudinal studies.